Minerva Urology and Nephrology 2022 October;74(5):642-6

DOI: 10.23736/S2724-6051.22.04959-X

language: English

Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer

Fabrizio DI MAIDA ¹, Antonio A. GROSSO ¹, Riccardo TELLINI ¹, Luca LAMBERTINI ¹, Mattia LO RE ¹, Anna CADENAR ¹, Sofia GIUDICI ¹, Roberta GIORGIONE ², Virginia ROSSI ², Lorenzo ANTONUZZO ², Andrea MINERVINI ¹, Andrea MARI ¹ ✉

ACCESS OPTIONS

Purchase access

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of .

Downloading and printing for personal use allowed.

Regain access

Personal subscriptions

Access as an individual subscriber

Institutional access

Access through your institution

Subscribe to this journal

Subscribe to Minerva Urology and Nephrology

Recommend to your librarian

top of page

YOUR ACCOUNT

YOUR ORDERS

SHOPPING BASKET

HOW TO ORDER

YOUR SUBSCRIPTIONS

YOUR ARTICLES

YOUR EBOOKS

COUPON

ACCESSIBILITY

Minerva Urology and Nephrology 2022 October;74(5):642-6

Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer

Publication History

Cite this article as

Corresponding author e-mail

Share